AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tagvilda M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Goldline Pharmaceuticals Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Tagvilda M 500mg/50mg Tablet

Metformin/Glimepiride 500mg/50mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two effective agents. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. This medication may be used alone or in conjunction with other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Effective blood sugar control helps prevent future complications. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly influence diabetes management. Common adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is possible, especially when used with insulin or sulfonylureas; learn its symptoms and management. This medication isn't universally suitable. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or lactating individuals require medical consultation. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose throughout treatment.

Uses of Tagvilda M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Tagvilda M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Tagvilda M 500mg/50mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with food.

Common Side effects of Tagvilda M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Tagvilda M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Tagvilda M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with a meal.

How Tagvilda M 500mg/50mg Tablet works:

Tagvilda M 500mg/50mg tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Tagvilda M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tagvilda M 500mg/50mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tagvilda M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Tagvilda M 500mg/50mg tablets cautiously. Dosage modification for Tagvilda M 500mg/50mg tablets may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Use of Tagvilda M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Tagvilda M 500mg/50mg Tablet :

Should you forget a dose of Tagvilda M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tagvilda M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tagvilda M 500mg/50mg Tablet

Tagvilda M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Tagvilda M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Tagvilda M 500mg/50mg Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Tagvilda M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Tagvilda M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in individuals with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Tagvilda M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Tagvilda M 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Tagvilda M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your doctor.
Tagvilda M 500mg/50mg Tab...
90
MRP 110
18% off